policy

Politics By Rachel Cohrs

Top Senate Democrat heads back to drawing board on drug pricing

Politics By Lev Facher

Do public health officials need to be political activists? A fight over an HIV crisis renews the question

Health By Alicia Diaz

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

Politics By Nicholas Florko and Rachel Cohrs

Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support

First Opinion By Joe Lonsdale

FTC’s challenge to Illumina’s vertical merger with Grail is all wrong

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile 

Opinions+ By Patrick McLaughlin and Tyler Richards

The FDA should embrace remote and automated drug inspection technology

Politics By Rachel Cohrs

The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry

Politics By Nicholas Florko

Hints emerge about a key Senate committee’s plans for health care

First Opinion By Ethan Dmitrovsky

Rethinking triage in an era of vaccine nationalism

First Opinion Podcast By Patrick Skerrett

Listen: Two addiction specialists debunk the myth of ‘excited delirium’ used in police encounters

Politics By Nicholas Florko

PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform

Opinions+ By Pierre Bourdage

Three steps toward creating a functioning U.S. biosimilars market

First Opinion By Michael Carney

Make it easier for employers to help get America vaccinated

Politics By Lev Facher

Inside the White House’s push for a new, $6.5 billion agency aimed at curing cancer 

Politics By Rachel Cohrs

Biden pushes Congress to boost public health, pandemic preparedness funding

First Opinion By Lubab al-Quraishi

Foreign-trained doctors like me were asked to help fight Covid-19. Now we’re being tossed aside

First Opinion Podcast By Patrick Skerrett

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

First Opinion By Dinesh Thakur

India shouldn’t insist on ‘bridging trials’ in the middle of a pandemic

Politics By Rachel Cohrs

There’s no point person in Biden’s HHS for its $187 billion Covid-19 fund for health care providers

First Opinion By Dorit R. Reiss, I. Glenn Cohen and Carmel Shachar

‘Authorization’ status is a red herring when it comes to mandating Covid-19 vaccination

First Opinion By Alvin E. Roth and Greg Segal

Reforming and improving organ transplant systems will save lives, taxpayer dollars

First Opinion By Julia Barnes-Weise and Kendall Hoyt

MAPGuide: A tool to help improve health-related public-private partnership agreements

First Opinion By Brian Spisak

Vaccination certificates won’t end lockdown. Prosocial approaches will

Politics By Rachel Cohrs

Here are the drug pricing policy options Democrats could use to pay for their next big legislative push

Opinions+ By Krishanu Saha

A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop

Politics By Rachel Cohrs

Senate reaches deal to extend Medicare pay bump for health care providers through 2021

Health By Dalia Faheid

Undocumented immigrants sought far less health care after Trump launched his campaign, new study shows 

First Opinion By Nathaniel Hupert, Michael G. Klein and John A. ("Jack") Muckstadt

Operations research advice for Covid-19 vaccination planners: think bigger, move faster